Blood Collection Devices Market Analysis and Forecast to 2031: By Product (Blood Collection Tubes, Needles & Syringes, Others), Method (Manual Blood Collection, Automated Blood Collection), End User (Hospitals & Clinics, Diagnostic & Pathology Centers, Bl

Blood Collection Devices Market Analysis and Forecast to 2031: By Product (Blood Collection Tubes, Needles & Syringes, Others), Method (Manual Blood Collection, Automated Blood Collection), End User (Hospitals & Clinics, Diagnostic & Pathology Centers, Blood Banks, Others) and Region

The global blood collection devices market size was USD 5.9 billion in 2021 and it is anticipated to reach USD 10.8 billion in 2031, growing at a rate of 6.3% from 2022-2031.

Blood collection devices help in the safe withdrawal of blood. Blood is collected from donors to perform various diagnostic tests. Needles & rings, lancets, and other devices are used for arterial and venous blood collection. Arterial blood collection has certain advantages like arterial blood gas sampling and intraoperative blood salvage. However, the growing number of accidents & trauma cases, rising incidence of infectious disease, and the developing liquid biopsy technology have improved associated healthcare processes. However, the shortage of qualified personnel will impede the market growth. Moreover, the growth opportunities among emerging nations are likely to offer significant opportunities for the growth of the global blood collection devices market.

Blood Collection Devices Market Scope and Structure Analysis

Market Trends and Drivers

The major factor boosting the growth of the market is the increasing prevalence of infectious diseases with the emergence of newer pathogens and chronic & lifestyle diseases. The increasing prevalence of infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis are a major factor driving the demand for effective blood collection (owing to the risk of disease transmission during blood transfusion). According to the WHO, (July 2021), there were an estimated 37.7 million [30.2–45.1 million] people living with HIV at the end of 2020, over two-thirds of whom (25.4 million) are in the WHO African Region. In 2020, 680,000 [480,000–1.0 million] people died from HIV-related causes, and 1.5 million [1.0–2.0 million] people acquired HIV. Adding to that, according to the WHO (July 2021), worldwide, there were an estimated 7 million new syphilis infections in 2020.

The burden of chronic diseases is rapidly increasing across the globe. Almost half of the total chronic disease deaths are attributable to cardiovascular disease (CVD). In the US alone, as per the American Heart Association, the prevalence of CVD is projected to increase from 36.9% in 2010 to 38.7% by 2020 and 40.5% by 2030. Obesity coupled with diabetes is also showing worrying trends because they already affect a large proportion of the population and because they have started to appear earlier in life. The prevalence of lifestyle diseases is also growing across the world, particularly in emerging countries.

This scenario has ensured greater adherence to health check-ups combined with the growing importance of markers to find disease conditions mainly via blood collection. Health check-ups are gaining popularity both at a personal level as well as performed at a corporate level for employee well-being. This will be favorable for the market growth and a significant contributor to the blood collection devices market, as blood tests are a primary approach to diagnosing these diseases.

Market Restraints & Challenges

One of the primary challenges in the growth of the global blood collection devices market is the high cost of automated blood collection devices. For blood banks, capital investments in automated blood collection using apheresis devices are very high in comparison to that of whole-blood collection. The average price for devices ranges between USD 45,000 and USD 55,000. So, smaller blood banks and hospitals do not opt for this type of blood collection. The cost of therapeutic apheresis is also very high, as it comprises the additional cost of disposables—between USD 1,500 and USD 3,000 per patient. Due to their high costs, the adoption of these automated blood collection products is very minimal as compared to manual blood collection products in countries such as China and India. This is limiting the overall growth of the blood collection devices market.

The cost of providing apheresis therapy is a matter of almost universal concern. Estimates of costs of individual apheresis treatments are very much available but vary widely. For example, in the US, the cost of an apheresis procedure is approximately USD 2,500 per treatment. An investment of USD 19,000 to USD 32,000 for a blood cell separator is the initial cost for setting up the machine, and disposable sets produced by manufacturers will vary between USD 40 and USD 90 per treatment. Replacement fluids (at an average volume of 2.8 liters), like albumin or fresh frozen plasma, make up the remainder of the costs, running from USD 125 to USD 600 per treatment.

Global Blood Collection Devices Market Segmentation

The report analyses the blood collection devices market based on product, method, end-user, and regions.

Global Blood Collection Devices Market by Product

On the basis of product, it is segmented into blood collection tubes, needles and syringes, and others. The key factors such as the strong prevalence of chronic diseases combined with technological advancements in blood collection devices are boosting the growth of the segment during the forecast period. Blood collection tubes witnessing a great demand owing to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders, cancers such as leukaemia, lymphoma, myeloma, and myelodysplastic syndrome can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system.

Global Blood Collection Devices Market by Method

Based on the method, it is segmented into manual blood collection and automated blood collection. The key factors such as a steady increase in the number of patients suffering from these diseases and ailments and the growing number of accidents may boost the blood collection market during the forecast period. The manual blood collection segment is likely to dominate the market during the forecast period. The increasing number of accidents, as well as trauma cases worldwide, will witness lucrative growth opportunities during the forecast period.

Global Blood Collection Devices Market by End User

Based on end-users, it is segmented into hospitals & clinics, diagnostic & pathology centers, blood banks, and others. Surging incidence of infectious diseases comprising hepatitis, human immunodeficiency virus (HIV), tuberculosis, and human papillomavirus (HPV) among others will boost the demand for blood collection production. Moreover, the rising prevalence of lifestyle diseases across the globe enhances the growth of the market. The hospitals & clinics segment is likely to dominate the market during the forecast period. The key factors such as increasing demand for blood donations are also fuelling the demand of the blood collection devices market. For example, according to WHO, 112.5 million blood donations collected globally and there is an increase of 10.7 million blood donations from unpaid donors has been reported from 2008 to 2013.

Geographical Analysis of Global Blood Collection Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America (comprising the US and Canada) accounted for the largest share of the global blood collection devices, followed by Europe. Factors like the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America.

Major Players of the Global Blood Collection Devices Market

The global blood collection devices market report includes players such as Becton, Dickinson and Company (US), Haematonics (US), Terumo BCT (US), Fresenius Kabi AG (Germany), Grifols, S.A. (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Cardinal Health (US), Retractable Technologies (US), Liuyang Sanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), Jiangsu Micsafe Medical Technology CO., LTD. (China), Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Þ (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), Lmb Technologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK).

COVID-19 Analysis

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the blood collection devices market. Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not to offer tests that could not be performed safely. This affected the market negatively in the initial period of the pandemic, reducing the use of blood collection devices. Conversely, increasing caution and the rising testing volumes, along with the need for regular health and body check-ups will ensure market growth in a later phase.

Results now take an average of four to six days for the general population, much longer than the two to three days required before. This is because tests for hospital patients and symptomatic healthcare workers are prioritized and take one day on average, which has resulted in a delayed cycle. While it has affected market growth to some extent, the situation is expected to change for the better.

Recent Developments

• February 2022, Abacus dx launched the newest addition to Streck’s trusted blood collection tube portfolio, RNA Complete BCT.
• February 2022, BD has released UltraSafe Plus 2.25 mL, a new needle guard solution that improves the delivery of drugs and other biologic solutions,
• August 2021, Quest Diagnostics Incorporated has acquired Boca Raton based Nationwide Laboratory Services. With the acquisition, Quest will broaden access to diagnostic innovation and insights empowering better health for more communities in South Florida.
• June 2021, Greiner Bio-One introduced MiniCollect PIXIE Heel Incision Safety lancet for expanding its portfolio with a new safety lancet specially designed for heel incision and now has three different lancet types of offers to cover individual needs.
• April 2021, Terumo Blood an Cell Technologies and CSL Plasma announced collaboration to deliver a new plasma collection platform.
• November 2020, Intravactechnology OU introduced new packaging system for its blood collection devices set. The packaging is available in paper, plastic blister, and foil pack for 1,2, and 5 tube pack.
• July 2020, Mangolia Medical launched Steripath Gen 2 with integrated syringe, addressed to the patient with difficult intravenous access or the ‘hard stick’ patient population.

Blood Collection Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global blood collection devices market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
• A thorough analysis of aspects that boost and restrict the development of the market is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future blood collection devices market potential from 2021 to 2031 in terms of revenue.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global blood collection devices industry.

Frequently Asked QuestionsQ. How big is the blood collection devices market?Ans. The global blood collection devices market size was USD 5.9 billion in 2021 and it is anticipated to reach USD 10.8 billion in 2031, growing at a rate of 6.3% from 2022-2031.Q. What is the blood collection devices market growth rate?Ans. The growth rate of the blood collection devices market is 6.3% from 2022 to 2031.Q. Which region holds a major market share for the blood collection devices market?Ans. North America holds a major market share of the blood collection devices market in 2021.Q. Which segment accounted for the largest blood collection devices market share?Ans. By end-user, the hospital’s segment accounted for the largest blood collection devices market shareQ. Who are the key players in the blood collection devices market?Ans. The global blood collection devices market report includes players such as Becton, Dickinson and Company (US), Haematonics (US), Terumo BCT (US), Fresenius Kabi AG (Germany), Grifols, S.A. (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Cardinal Health (US), Retractable Technologies (US), Liuyang Sanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), Jiangsu Micsafe Medical Technology CO., LTD. (China), Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Þ (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), Lmb Technologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK).Q. What are the factors driving the blood collection devices market growth?Ans. The major factors driving the growth of the market are the increasing volume of surgeries and the growing prevalence of severe trauma injuries.Q. What are the key growth strategies of blood collection devices market players?Ans. The key growth strategies of blood collection devices market players are product launch and product approval.Q. Which region will provide more business opportunities for the blood collection devices market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for blood collection devices market during the forecast period

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.